These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29988527)

  • 1. Characterization of
    Gualdrón-López M; Flannery EL; Kangwanrangsan N; Chuenchob V; Fernandez-Orth D; Segui-Barber J; Royo F; Falcón-Pérez JM; Fernandez-Becerra C; Lacerda MVG; Kappe SHI; Sattabongkot J; Gonzalez JR; Mikolajczak SA; Del Portillo HA
    Front Microbiol; 2018; 9():1271. PubMed ID: 29988527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass Spectrometry Identification of Biomarkers in Extracellular Vesicles From Plasmodium vivax Liver Hypnozoite Infections.
    Gualdrón-López M; Díaz-Varela M; Zanghi G; Aparici-Herraiz I; Steel RWJ; Schäfer C; Cuscó P; Chuenchob V; Kangwangransan N; Billman ZP; Olsen TM; González JR; Roobsoong W; Sattabongkot J; Murphy SC; Mikolajczak SA; Borràs E; Sabidó E; Fernandez-Becerra C; Flannery EL; Kappe SHI; Del Portillo HA
    Mol Cell Proteomics; 2022 Oct; 21(10):100406. PubMed ID: 36030044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice.
    Mikolajczak SA; Vaughan AM; Kangwanrangsan N; Roobsoong W; Fishbaugher M; Yimamnuaychok N; Rezakhani N; Lakshmanan V; Singh N; Kaushansky A; Camargo N; Baldwin M; Lindner SE; Adams JH; Sattabongkot J; Kappe SH
    Cell Host Microbe; 2015 Apr; 17(4):526-35. PubMed ID: 25800544
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Flannery EL; Kangwanrangsan N; Chuenchob V; Roobsoong W; Fishbaugher M; Zhou K; Billman ZP; Martinson T; Olsen TM; Schäfer C; Campo B; Murphy SC; Mikolajczak SA; Kappe SHI; Sattabongkot J
    Mol Ther Methods Clin Dev; 2022 Sep; 26():427-440. PubMed ID: 36092359
    [No Abstract]   [Full Text] [Related]  

  • 5. A recombinant antibody against Plasmodium vivax UIS4 for distinguishing replicating from dormant liver stages.
    Schafer C; Dambrauskas N; Steel RW; Carbonetti S; Chuenchob V; Flannery EL; Vigdorovich V; Oliver BG; Roobsoong W; Maher SP; Kyle D; Sattabongkot J; Kappe SHI; Mikolajczak SA; Sather DN
    Malar J; 2018 Oct; 17(1):370. PubMed ID: 30333026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptic erythrocytic infections in Plasmodium vivax, another challenge to its elimination.
    Fernandez-Becerra C; Aparici-Herraiz I; Del Portillo HA
    Parasitol Int; 2022 Apr; 87():102527. PubMed ID: 34896615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel immortalized hepatocyte-like cell line (imHC) supports in vitro liver stage development of the human malarial parasite Plasmodium vivax.
    Pewkliang Y; Rungin S; Lerdpanyangam K; Duangmanee A; Kanjanasirirat P; Suthivanich P; Sa-Ngiamsuntorn K; Borwornpinyo S; Sattabongkot J; Patrapuvich R; Hongeng S
    Malar J; 2018 Jan; 17(1):50. PubMed ID: 29370800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium vivax pre-erythrocytic stages and the latent hypnozoite.
    Zanghi G; Vaughan AM
    Parasitol Int; 2021 Dec; 85():102447. PubMed ID: 34474178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver-stage fate determination in
    Vantaux A; Péneau J; Cooper CA; Kyle DE; Witkowski B; Maher SP
    Front Microbiol; 2022; 13():976606. PubMed ID: 36212849
    [No Abstract]   [Full Text] [Related]  

  • 10. Single-cell RNA profiling of 
    Ruberto AA; Maher SP; Vantaux A; Joyner CJ; Bourke C; Balan B; Jex A; Mueller I; Witkowski B; Kyle DE
    Front Cell Infect Microbiol; 2022; 12():986314. PubMed ID: 36093191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.
    Wells TN; Burrows JN; Baird JK
    Trends Parasitol; 2010 Mar; 26(3):145-51. PubMed ID: 20133198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial protection against P. vivax infection diminishes hypnozoite burden and blood-stage relapses.
    Schäfer C; Dambrauskas N; Reynolds LM; Trakhimets O; Raappana A; Flannery EL; Roobsoong W; Sattabongkot J; Mikolajczak SA; Kappe SHI; Sather DN
    Cell Host Microbe; 2021 May; 29(5):752-756.e4. PubMed ID: 33857426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No more monkeying around: primate malaria model systems are key to understanding Plasmodium vivax liver-stage biology, hypnozoites, and relapses.
    Joyner C; Barnwell JW; Galinski MR
    Front Microbiol; 2015; 6():145. PubMed ID: 25859242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the Tubovesicular Network in
    Sylvester K; Maher SP; Posfai D; Tran MK; Crawford MC; Vantaux A; Witkowski B; Kyle DE; Derbyshire ER
    Front Cell Infect Microbiol; 2021; 11():687019. PubMed ID: 34195101
    [No Abstract]   [Full Text] [Related]  

  • 15. Transfection Models to Investigate
    Voorberg-van der Wel A; Zeeman AM; Kocken CHM
    Pathogens; 2023 Aug; 12(9):. PubMed ID: 37764878
    [No Abstract]   [Full Text] [Related]  

  • 16. A Humanized Mouse Model for Plasmodium vivax to Test Interventions that Block Liver Stage to Blood Stage Transition and Blood Stage Infection.
    Schäfer C; Roobsoong W; Kangwanrangsan N; Bardelli M; Rawlinson TA; Dambrauskas N; Trakhimets O; Parthiban C; Goswami D; Reynolds LM; Kennedy SY; Flannery EL; Murphy SC; Sather DN; Draper SJ; Sattabongkot J; Mikolajczak SA; Kappe SHI
    iScience; 2020 Aug; 23(8):101381. PubMed ID: 32739836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser capture microdissection enables transcriptomic analysis of dividing and quiescent liver stages of Plasmodium relapsing species.
    Cubi R; Vembar SS; Biton A; Franetich JF; Bordessoulles M; Sossau D; Zanghi G; Bosson-Vanga H; Benard M; Moreno A; Dereuddre-Bosquet N; Le Grand R; Scherf A; Mazier D
    Cell Microbiol; 2017 Aug; 19(8):. PubMed ID: 28256794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of Plasmodium vivax centromere and promoter activities using Plasmodium yoelii.
    Thawnashom K; Kaneko M; Xangsayarath P; Chaiyawong N; Yahata K; Asada M; Adams JH; Kaneko O
    PLoS One; 2019; 14(12):e0226884. PubMed ID: 31860644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic identification of the contents of small extracellular vesicles from in vivo Plasmodium yoelii infection.
    De Sousa KP; Potriquet J; Mulvenna J; Sotillo J; Groves PL; Loukas A; Apte SH; Doolan DL
    Int J Parasitol; 2022 Jan; 52(1):35-45. PubMed ID: 34339723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The
    Gupta DK; Dembele L; Voorberg-van der Wel A; Roma G; Yip A; Chuenchob V; Kangwanrangsan N; Ishino T; Vaughan AM; Kappe SH; Flannery EL; Sattabongkot J; Mikolajczak S; Bifani P; Kocken CH; Diagana TT
    Elife; 2019 May; 8():. PubMed ID: 31094679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.